News > WHO advises against Gilead’s Remdesivir for all hospitalised Covid-19 patients

WHO advises against Gilead’s Remdesivir for all hospitalised Covid-19 patients

Gilead’s drug Remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a World Health Organization (WHO) panel said on November 20.

The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.